Medtronic and Abbott, both Dividend Kings, reward investors differently: Medtronic provides a higher current dividend yield of 3.22% with stronger cash flow coverage, making it better for retirees needing immediate income. Abbott, with a 2.49% yield, raises its dividend faster, suitable for investors with a longer time horizon who reinvest dividends. Medtronic's stock is cheaper and has solid revenue growth prospects, while Abbott's diverse revenue mix supports its faster dividend growth. For income now, Medtronic is preferred; for growth over 15+ years, Abbott leads.
Medtronic and Abbott's dividend strategies are reflected in their current trading on Pluang as of Oct 14, 2026 19:11 WIB. Medtronic trades at USD 93.29 with a dividend yield of 3.1% and shows steady buying interest with 100% buy orders. Abbott, priced higher at USD 103.40 with a 2.46% yield, sees a mix of buying and selling activity, with 64% buy orders. This suggests different investor preferences for income versus growth in the health sector stocks.
